A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma

NCT07015749 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: IBI3002

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]